Targets both GLP-1 and GIP receptors for advanced metabolic support and appetite regulation.
Designed to support appetite control, insulin sensitivity, and sustainable fat reduction through dual-action metabolic signaling.
Tirzepatide is an advanced FDA-approved medication used for chronic weight management and metabolic health support. It works by activating both GLP-1 and GIP receptors, two hormones involved in appetite regulation, insulin response, and energy metabolism.
Tirzepatide is often associated with medications such as Zepbound and Mounjaro. Zepbound is specifically approved and dosed for chronic weight management, while Mounjaro is commonly used for Type 2 Diabetes. During your consultation, your provider can review your health history, goals, and eligibility to determine the appropriate treatment path.
At Mindful Wellness, Tirzepatide treatment is combined with physician oversight, lifestyle guidance, and ongoing monitoring to support long-term success safely and sustainably.
Tirzepatide supports more than weight reduction. It is designed to improve metabolic function, appetite regulation, and long-term health outcomes through a physician-guided treatment approach.
We follow a precision-based escalation protocol to minimize side effects while maximizing metabolic response.
Complete a comprehensive health assessment and blood work to ensure Zepbound is the right choice for your biology.
Meet with our clinical team to review your health profile, determine eligibility, and create a personalized Tirzepatide treatment plan.
Personalized treatment plans designed around your metabolic goals.
FDA-backed protocols with rigorous screening to ensure your safety at every stage of treatment.
Common side effects may include nausea, reduced appetite, digestive discomfort, constipation, or fatigue during dosage escalation. Most symptoms are temporary and improve as the body adjusts.
Tirzepatide is an advanced physician-guided treatment designed to support sustainable weight loss, appetite regulation, and long-term metabolic health. At Mindful Wellness, every treatment plan is personalized to your biology, goals, and lifestyle for safe and effective results.
Required baseline testing
Zepbound (Tirzepatide) is the first and only FDA approved medication that activates both GIP and GLP 1 hormone receptors. These tests ensure safe prescribing.
Assessment of liver and kidney function to ensure safe medication processing
Precise measurement of blood sugar control and insulin resistance levels
Baseline lipid profile and blood pressure monitoring protocols
Clinical results
Zepbound (Tirzepatide) is the first and only FDA approved medication that activates both GIP and GLP 1 hormone receptors.
15mg dose, 72 weeks
91% vs 35% placebo
Visceral fat reduction
Prescribed and supervised by Dr. Gupta
Zepbound and Wegovy are both weight management medications, but they work slightly differently. Zepbound targets two hormones (GLP-1 and GIP), which may enhance appetite control and blood sugar regulation. Wegovy works on GLP-1 alone. Both are effective, but your doctor will recommend the best option based on your health needs.
These medications are given as a once-weekly injection under the skin (subcutaneous injection). You can typically inject it at home using a pre-filled pen, commonly in the abdomen, thigh, or upper arm, following your provider’s instructions.
Insurance coverage for Tirzepatide can vary depending on your provider, plan, and eligibility requirements. Please contact your insurance company directly to confirm whether weight loss treatment with Tirzepatide is covered under your policy.
